Vancouver, B.C., December 8, 2020 – WELL Health Technologies Corp. (TSX: WELL) (the “Company” or “WELL”), a company focused on consolidating and modernizing clinical and digital assets within the primary healthcare sector, is pleased to announce it has granted an aggregate of 1,039,171 restricted share units (each, a “RSU”) to certain key employees and consultants of the Company pursuant to the Company’s Omnibus Equity Incentive Plan (the “Incentive Plan”).
Each RSU represents the right to receive, once vested, one common share in the capital of the Company. Vesting shall be generally in line with WELL’s common practices pursuant to its corporate policies and Incentive Plan.
The Company also announces it has granted an aggregate of 291,786 performance share units (each, a “PSU”) to certain employees and consultants pursuant to the Incentive Plan. Each PSU represents the right to receive, once vested and performance criteria are met, one common share in the capital of the Company.
The Company also announces it has granted an aggregate of 105,000 stock options (each, an “Option”) to certain employees and a consultant pursuant to its Incentive Plan, at an exercise price of $6.94 per common share. Such price is based on the prior 5 day volume weighted average price of the Company’s stock as quoted on the Toronto Stock Exchange. Each Option granted to the optionee is exercisable for a period of 5 years. Vesting shall be generally in line with WELL’s corporate policies and Incentive Plan.
WELL HEALTH TECHNOLOGIES CORP.
Per: “Hamed Shahbazi”
Hamed Shahbazi
Chief Executive Officer, Chairman and Director
About WELL
WELL is an omni-channel digital health company whose overarching objective is to empower doctors to provide the best and most advanced care possible while leveraging the latest technology and trends in digital health. As such, WELL owns and operates 20 primary healthcare medical clinics, is Canada’s third largest Electronic Medical Records (EMR) supplier serving over 2,000 medical clinics, operates a leading national telehealth service and is a provider of digital health, billing and cybersecurity related technology solutions. WELL is an acquisitive company that follows a disciplined and accretive capital allocation strategy. The Company is publicly traded on the Toronto Stock Exchange under the symbol “WELL”. WELL was recognized as a TSX Venture 50 Company three years in a row in 2018, 2019 and 2020. To access WELL’s telehealth service, visit: virtualclinics.ca and for corporate information, visit: www.well.company.
Neither the Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information:
Pardeep S. Sangha
Vice President Corporate Strategy and Investor Relations
WELL Health Technologies Corp.
604-572-6392
